Conor Cobalt Chromium Reservoir Based Stent With Sirolimus Elution in Native Coronary Artery Lesions

Stopped The NEVO™ stent will not be commercialized. Cordis decided to close the study after 3 years. This decision took the absence of safety signals into account.

Conditions

• Coronary Disease

Interventions

• DEVICE: NEVO™ Sirolimus-eluting Coronary Stent System

Sponsor

Cordis US Corp.

Collaborators

• [object Object]